Dimensional Fund Advisors LP Sangamo Therapeutics, Inc Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 493,686 shares of SGMO stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

493,686

Previous 518,203 4.73%

Holding current value

$1.01 Million

Previous $186,000 127.96%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$0.32 - $1.1 $7,845 - $26,968	-24,517 Reduced 4.73%	493,686 $424,000
Q2 2024 Aug 09, 2024	SELL	$0.36 - $0.65 $12,483 - $22,539	-34,676 Reduced 6.27%	518,203 $186,000
Q1 2024 May 10, 2024	SELL	$0.42 - $1.38 $9,318 - $30,616	-22,186 Reduced 3.86%	552,879 $370,000
Q4 2023 Feb 07, 2024	SELL	$0.3 - $0.63 $68,647 - $144,160	-228,826 Reduced 28.46%	575,065 $310,000
Q3 2023 Nov 09, 2023	SELL	$0.58 - $1.47 $427,882 - $1.08 Million	-737,729 Reduced 47.85%	803,891 $482,000
Q2 2023 Aug 09, 2023	SELL	$1.11 - $1.74 $1.96 Million - $3.07 Million	-1,761,737 Reduced 53.33%	1,541,620 $2 Million
Q1 2023 May 12, 2023	SELL	$1.66 - $3.67 $233,937 - $517,198	-140,926 Reduced 4.09%	3,303,357 $5.81 Million
Q4 2022 Feb 09, 2023	BUY	$2.77 - $5.07 $1.03 Million - $1.89 Million	373,442 Added 12.16%	3,444,283 $10.8 Million
Q3 2022 Nov 10, 2022	SELL	$4.27 - $6.39 $54,596 - $81,702	-12,786 Reduced 0.41%	3,070,841 $15 Million
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.21 $796,167 - $1.51 Million	242,734 Added 8.54%	3,083,627 $12.8 Million
Q1 2022 May 13, 2022	BUY	$5.23 - $7.82 $3.21 Million - $4.8 Million	614,426 Added 27.6%	2,840,893 $16.5 Million
Q4 2021 Feb 09, 2022	SELL	$7.29 - $10.97 $654,204 - $984,447	-89,740 Reduced 3.87%	2,226,467 $16.7 Million
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $6.22 Million - $8.29 Million	-690,271 Reduced 22.96%	2,316,207 $20.9 Million
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $3.57 Million - $4.44 Million	351,101 Added 13.22%	3,006,478 $36 Million
Q1 2021 May 14, 2021	BUY	$10.88 - $17.05 $3.26 Million - $5.1 Million	299,322 Added 12.7%	2,655,377 $33.3 Million
Q4 2020 Feb 25, 2021	BUY	$9.23 - $18.18 $21.7 Million - $42.8 Million	2,356,055 New	2,356,055 $36.8 Million

Others Institutions Holding SGMO

# of Institutions

114

Shares Held

56.3M

Call Options Held

576K

Put Options Held

1.17M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $321M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Sangamo Therapeutics, Inc Transaction History